Aurora Investment Counsel acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 22,611 shares of the company’s stock, valued at approximately $1,580,000.
Several other large investors have also added to or reduced their stakes in HSIC. Vanguard Group Inc. boosted its position in shares of Henry Schein by 3.0% in the 2nd quarter. Vanguard Group Inc. now owns 8,086,317 shares of the company’s stock valued at $1,479,959,000 after purchasing an additional 236,862 shares during the period. FMR LLC boosted its position in shares of Henry Schein by 0.4% in the 2nd quarter. FMR LLC now owns 6,921,367 shares of the company’s stock valued at $1,266,749,000 after purchasing an additional 24,935 shares during the period. BlackRock Inc. boosted its position in shares of Henry Schein by 1.8% in the 2nd quarter. BlackRock Inc. now owns 5,696,685 shares of the company’s stock valued at $1,042,607,000 after purchasing an additional 101,406 shares during the period. Alecta Pensionsforsakring Omsesidigt boosted its position in shares of Henry Schein by 112.0% in the 3rd quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock valued at $435,693,000 after purchasing an additional 2,806,990 shares during the period. Finally, Mackenzie Financial Corp boosted its position in shares of Henry Schein by 106.0% in the 3rd quarter. Mackenzie Financial Corp now owns 3,938,233 shares of the company’s stock valued at $322,896,000 after purchasing an additional 2,026,867 shares during the period. 91.69% of the stock is owned by institutional investors and hedge funds.
In other news, Director Barry J. Alperin sold 5,796 shares of the stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $70.76, for a total transaction of $410,124.96. Following the completion of the transaction, the director now directly owns 48,172 shares of the company’s stock, valued at approximately $3,408,650.72. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 1.19% of the company’s stock.
A number of analysts recently issued reports on the company. UBS Group reissued a “buy” rating on shares of Henry Schein in a research report on Friday, September 15th. Piper Jaffray Companies raised Henry Schein from a “neutral” rating to an “overweight” rating in a research report on Friday, September 15th. Jefferies Group reissued a “hold” rating and issued a $89.00 target price on shares of Henry Schein in a research report on Friday, October 20th. Robert W. Baird set a $95.00 target price on Henry Schein and gave the company a “buy” rating in a research report on Thursday, October 19th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and set a $89.00 price objective on shares of Henry Schein in a research report on Thursday, October 19th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $84.23.
Shares of Henry Schein, Inc. (NASDAQ:HSIC) opened at $73.30 on Friday. Henry Schein, Inc. has a 1 year low of $65.28 and a 1 year high of $93.50. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.86 and a current ratio of 1.55. The firm has a market capitalization of $11,500.00, a P/E ratio of 21.12, a price-to-earnings-growth ratio of 1.89 and a beta of 0.99.
Henry Schein (NASDAQ:HSIC) last issued its earnings results on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.03). The business had revenue of $3.16 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The business’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period last year, the company posted $0.84 earnings per share. equities analysts predict that Henry Schein, Inc. will post 3.6 earnings per share for the current fiscal year.
Henry Schein declared that its Board of Directors has initiated a share repurchase program on Monday, September 18th that allows the company to buyback $400.00 million in shares. This buyback authorization allows the company to repurchase up to 6.3% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s management believes its stock is undervalued.
TRADEMARK VIOLATION WARNING: “Aurora Investment Counsel Invests $1.58 Million in Henry Schein, Inc. (NASDAQ:HSIC) Stock” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.dispatchtribunal.com/2018/01/12/aurora-investment-counsel-acquires-new-stake-in-henry-schein-inc-hsic.html.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.